ICF Core Sets: How to specify impairment and function in systemic lupus erythematosus

Lupus

Volumn 15, Issue 4, 2006, Pages 248-253

  Aringer, Martin ^a   Stamm, T A ^a,b,c   Pisetsky, D S ^d,e   Yarboro, C H ^f   Cieza, A ^b   Smolen, J S ^a,g   Stucki, G ^b,c  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b German Institute of Medical Documentation and Information DIMDI   (Germany)

^c UNIVERSITY OF MUNICH   (Germany)

^d DURHAM VA MEDICAL CENTER   (United States)

^e DUKE UNIVERSITY MEDICAL CENTER   (United States)

^f NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES   (United States)

^g GENERAL HOSPITAL LINZ   (Austria)

Author keywords

Impairment; Quality of life; Systemic lupus erythematosus; World Health Organization

Indexed keywords

CONSENSUS DEVELOPMENT; DECISION MAKING; DISEASE SEVERITY; EMPIRICISM; ETHNIC DIFFERENCE; HUMAN; INTERNATIONAL CLASSIFICATION OF FUNCTIONING, DISABILITY AND HEALTH; MEDICAL LITERATURE; PATIENT CARE; PRIORITY JOURNAL; REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS; WORLD HEALTH ORGANIZATION; WOUND HEALING IMPAIRMENT;

CONSENSUS DEVELOPMENT CONFERENCES; DELPHI TECHNIQUE; EMPIRICAL RESEARCH; FOCUS GROUPS; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; QUALITY OF LIFE; RESEARCH DESIGN; SEVERITY OF ILLNESS INDEX; WORLD HEALTH ORGANIZATION;

EID: 33646245456     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1191/0961203306lu2298xx     Document Type: Review

References (23)

1. Wang B, Gladman DD, Urowitz MB. Fatigue in lupus is not correlated with disease activity. J Rheumatol 1998; 25: 892-895.
2. Gladman DD, Urowitz MB, Ong A, Gough J, MacKinnon A. A comparison of five health status instruments in patients with systemic lupus erythematosus (SLE). Lupus 1996; 5: 190-195.
3. WHO. ICF - International classification of functioning, disability and health. World Health Organization, Geneva, 2001.
4. Ustun B, Chatterji S, Kostanjsek N. Comments from WHO for the Journal of Rehabilitation Medicine Special Supplement on ICF Core Sets. J Rehabil Med 2004; 44(suppl): 7-8.
5. Stucki G, Grimby G. Applying the ICF in medicine. J Rehabil Med 2004; 44(suppl): 5-6.
6. Stucki G, Ewert T, Cieza A. Value and application of the ICF in rehabilitation medicine. Disabil Rehabil 2003; 25: 628-634.
7. Stucki G, Cieza A. The International Classification of Functioning, Disability and Health (ICF) Core Sets for rheumatoid arthritis: a way to specify functioning. Ann Rheum Dis 2004; 63(Suppl 2): ii40-ii45.
8. Stucki G, Cieza A, Geyh S et al. ICF Core Sets for rheumatoid arthritis. J Rehabil Med 2004; 44(suppl): 87-93.
9. Hay EM, Bacon PA, Gordon C et al. The BILAG index: a reliable and valid instrument for measuring clinical disease activity in systemic lupus erythematosus. Q J Med 1993; 86: 447-458.
10. Vitali C, Bencivelli W, Isenberg DA et al. Disease activity in systemic lupus erythematosus: report of the Consensus Study Group of the European Workshop for Rheumatology Research. II. Identification of the variables indicative of disease activity and their use in the development of an activity score. The European Consensus Study Group for Disease Activity in SLE. Clin Exp Rheumatol 1992; 10: 541-547.
11. Smolen JS. Clinical and serologic features: Incidence and diagnostic approach. In Smolen JS, Zielinski CC eds. Systemic lupus erythematosus. Springer, 1987: 171-196.
12. Liang MH, Socher SA, Larson MG, Schur PH. Reliability and validity of six systems for the clinical assessment of disease activity in systemic lupus erythematosus. Arthritis Rheum 1989; 32: 1107-1118.
13. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum 1992; 35: 630-640.
14. Bencivelli W, Vitali C, Isenberg DA et al. Disease activity in systemic lupus erythematosus: report of the Consensus Study Group of the European Workshop for Rheumatology Research. III. Development of a computerised clinical chart and its application to the comparison of different indices of disease activity. The European Consensus Study Group for Disease Activity in SLE. Clin Exp Rheumatol 1992; 10: 549-554.
15. Gladman DD, Urowitz MB. The SLICC/ACR damage index: progress report and experience in the field. Lupus 1999; 8: 632-637.
16. Delbeq A, Van de Ven AH, Gustofon FH. Group techniques for program planning. A guide to nominal group and Delphi processes. Scott, Foresman and Company, 1997.
17. Sacket DL, Strauss SE, Richardson WS, Rosenberg W, Haynes RB. How to practice and teach EBM. Churchill Livingstone, 2000.
18. Cieza A, Brockow T, Ewert T et al. Linking health-status measurements to the international classification of functioning, disability and health. J Rehabil Med 2002; 34: 205-210.
19. Clarke A. Focus group interviews in health-care research. Prof Nurse 1999; 14: 395-397.
20. Parsons M, Greenwood J. A guide to the use of focus groups in health care research: Part 1. Contemp Nurse 2000; 9: 169-180.
21. Linstone HA, Turoff M. The Delphi technique: techniques and applications. Addison Wesley, 1975.
22. WHO. ICF Checklist version 2.1a, clinical form for international classification of functioning, disability and health: ICF. World Health Organization, 2001.
23. Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992; 30: 473-483.